COVID-19: regulatory implications for the UK and European life sciences industry
Marie Manley and co-authors from Sidley Austin explain the updates to regulations in the EU and UK in light of the COVID-19 coronavirus pandemic.
List view / Grid view
Marie Manley and co-authors from Sidley Austin explain the updates to regulations in the EU and UK in light of the COVID-19 coronavirus pandemic.
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa...
Researchers have identified that stroke patients with dementia treated with IVT, using clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients...
Researchers have described a new method to study biochemical changes that occur in the pancreas during the development of diabetes...
27 March 2017 | By Niamh Marriott, Junior Editor
Umecrine Cognition AB announced the inclusion of the first patient in a clinical Phase Ib/IIa study of GR3027, to treat Hepatic Encephalopathy...
3 April 2014 | By Karolinska Institutet
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer...
IN this Informatics In-Depth Focus: Using LIMS for biobanking and implementing LIMS for research; Biologics development and ELN: A good match?; Informatics Roundtable...
21 March 2013 | By AstraZeneca
The Centre will be set up to conduct preclinical and clinical studies...
24 January 2013 | By Cision
“Anders Hamsten will be an excellent president. It is also very gratifying that he has solid support from within the organisation”